Hedge Fund Citadel Takes Short Position in GSK, FT Reports
Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, according to data from the Financial Conduct Authority, the FT report said.
Griffon initiated with a Buy at Loop Capital
Loop Capital last night initiated coverage of Griffon (GFF) with a Buy rating and $95 price target The analyst believes the step up in the ...
Loop Capital sets $95 target on Griffon stock with buy rating
Loop Capital Markets initiated coverage on Griffon Corporation (NYSE:GFF), assigning a Buy rating to the company's shares with a price target of $95.00. The firm's analyst, Jeffrey Stevenson, ...
Financial Planning1h
Advisor moves: Rockefeller, LPL recruit; Hightower CEO stepping down
LPL Financial picked up a couple of new teams and RIA aggregators Corient and Prime Capital entered into some big ...